Pulmonary infection of cystic fibrosis mice with Staphylococcus aureus requires expression of α-toxin

被引:17
|
作者
Keitsch, Simone [1 ]
Riethmueller, Joachim [2 ]
Soddemann, Matthias [1 ]
Sehl, Carotin [1 ]
Wilker, Barbara [1 ]
Edwards, Michael J. [3 ]
Caldwell, Charles C. [3 ]
Fraunholz, Martin [4 ]
Gulbins, Erich [1 ,3 ]
Becker, Katrin Anne [1 ]
机构
[1] Univ Duisburg Essen, Med Sch, Dept Mol Biol, Hufelandstr 55, D-45122 Essen, Germany
[2] Univ Tubingen, Childrens Clin, Ctr Pediat Clin Studies, Hoppe Seyler Str 1, D-72076 Tubingen, Germany
[3] Univ Cincinnati, Coll Med, Dept Surg, 231 Albert Sabin Way, Cincinnati, OH 45267 USA
[4] Univ Wurzburg, Chair Microbiol, D-97074 Wurzburg, Germany
关键词
ceramide; cystic fibrosis; pneumonia; sphingosine; Staphylococcus aureus; toxins; AIRWAY EPITHELIUM; FUNCTIONAL INHIBITORS; LUNG INFECTION; HOST-DEFENSE; INFLAMMATION; CERAMIDE; SPHINGOMYELINASE; IDENTIFICATION; GENE; ADAM10;
D O I
10.1515/hsz-2018-0161
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pulmonary infections of cystic fibrosis (CF) patients with Staphylococcus aureus (S. aureus) occur very early in the disease. The molecular details that cause infection-susceptibility of CF patients to and mediate infection with S. aureus are poorly characterized. Therefore, we aimed to identify the role of alpha-toxin, a major S. aureus toxin, for pulmonary infection of CF mice. Infection with S. aureus JE2 resulted in severe pneumonia in CF mice, while wildtype mice were almost unaffected. Deficiency of alpha-toxin in JE2-Delta hla reduced the pathogenicity of S. aureus in CF mice. However, CF mice were still more susceptible to the mutant S. aureus strain than wildtype mice. The S. aureus JE2 induced a marked increase of ceramide and a downregulation of sphingosine and acid ceramidase expression in bronchi of CF mice. Deletion of alpha-toxin reduced these changes after infection of CF mice. Similar changes were observed in wildtype mice, but at much lower levels. Our data indicate that expression of a-toxin is a major factor causing S. aureus infections in CF mice. Wildtype S. aureus induces a marked increase of ceramide and a reduction of sphingosine and acid ceramidase expression in bronchial epithelial cells of wildtype and CF mice, changes that determine infection susceptibility.
引用
收藏
页码:1203 / 1213
页数:11
相关论文
共 50 条
  • [41] Antimicrobial Treatment of Staphylococcus aureus in Patients With Cystic Fibrosis
    Esposito, Susanna
    Pennoni, Guido
    Mencarini, Valeria
    Palladino, Nicola
    Peccini, Laura
    Principi, Nicola
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [42] Staphylococcus aureus in Early Cystic Fibrosis Lung Disease
    Wong, John K.
    Ranganathan, Sarath C.
    Hart, Emily
    PEDIATRIC PULMONOLOGY, 2013, 48 (12) : 1151 - 1159
  • [43] Genomic Staphylococcus aureus adaptation to the cystic fibrosis lung
    Hirschhausen, N.
    Neumann, C.
    Goesmann, A.
    Peters, G.
    Kahl, B.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2011, 301 : 51 - 51
  • [44] Staphylococcus Aureus Acquisition in Hispanic Children with Cystic Fibrosis
    McGarry, M.
    Nielson, D. W.
    Ly, N. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [45] STAPHYLOCOCCUS-AUREUS EMPYEMA IN CYSTIC-FIBROSIS
    TAUSSIG, LM
    BELMONTE, MM
    BEAUDRY, PH
    JOURNAL OF PEDIATRICS, 1974, 84 (05): : 724 - 727
  • [46] Staphylococcus aureus in cystic fibrosis:: Implications for prognosis and treatment
    Döring, G
    PEDIATRIC PULMONOLOGY, 1997, : 235 - 236
  • [47] Long-term Pulmonary Function in Pediatric Cystic Fibrosis Patients with Chronic Methicillin-Sensitive Staphylococcus Aureus Infection
    Sunman, B.
    Yalcin, E.
    Ozsezen, B.
    Ademhan, Tural D.
    Nayir, Buyuksahin H.
    Guzelkas, I.
    Emiralioglu, N.
    Dogru, D.
    Ozcelik, U.
    Kiper, N.
    PEDIATRIC PULMONOLOGY, 2021, 56 : S128 - S128
  • [48] Immunopathogenesis of Staphylococcus aureus pulmonary infection
    Parker, Dane
    Prince, Alice
    SEMINARS IN IMMUNOPATHOLOGY, 2012, 34 (02) : 281 - 297
  • [49] Immunopathogenesis of Staphylococcus aureus pulmonary infection
    Dane Parker
    Alice Prince
    Seminars in Immunopathology, 2012, 34 : 281 - 297
  • [50] USE OF FOSFOMYCIN/TOBRAMYCIN INHALATION FOR THE TREATMENT OF PULMONARY INFECTIONS BY STAPHYLOCOCCUS AUREUS IN PATIENTS WITH CYSTIC FIBROSIS
    Penenory, P. A.
    Laura, M. L.
    Pinero, R. F.
    Cipriani, S. A.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S294 - S294